Femalefil
Femalefil Price range: $ 46,00 through $ 89,00
Back to products
Ferrous
Ferrous Price range: $ 60,00 through $ 487,00

Femalegra

Price range: $ 50,00 through $ 305,00

Femalegra is a specialized medication designed to enhance the sexual health and satisfaction of women. By increasing blood flow to the pelvic region, this product helps improve sensitivity and overall physical response during intimate activities. It is primarily used to address symptoms of female sexual interest/arousal disorder, helping individuals regain a fulfilling and pleasurable experience. Many users report experiencing heightened arousal, improved natural lubrication, and more intense climaxes when using this treatment. This reliable solution provides a supportive way to boost confidence and enjoy a more vibrant, satisfying intimate life.

Active substance: Sildenafil
SKU: Femalegra Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Femalegra contains sildenafil citrate, which belongs to the therapeutic class of phosphodiesterase type 5 (PDE5) inhibitors. In the United States, sildenafil citrate is a prescription-only active ingredient primarily approved by the Food and Drug Administration (FDA) for specific cardiovascular and male reproductive conditions, whereas products marketed under the brand name Femalegra represent an unapproved, off-label formulation intended for female sexual dysfunction.

Any therapeutic application of sildenafil in female populations is considered an off-label medical use and must be evaluated, prescribed, and monitored by a qualified healthcare professional. The dispensing of sildenafil-containing products in the United States is strictly governed by federal and state prescription regulations, requiring a valid prescription from a licensed healthcare provider.

Parameter Details
Active ingredient (INN) Sildenafil citrate
Therapeutic class Phosphodiesterase type 5 (PDE5) inhibitor
Dosage form Oral tablet
Route of administration Oral
Prescription status Prescription (Rx only)
Primary purpose Off-label management of female sexual interest/arousal disorder

Pharmacological Profile and Clinical Overview

How the drug works

Sildenafil acts through the selective inhibition of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Phosphodiesterase type 5 is an enzyme responsible for the degradation of cGMP in vascular smooth muscle cells. By inhibiting PDE5, sildenafil enhances the downstream signaling of nitric oxide (NO), leading to elevated cGMP concentrations. This biochemical cascade causes smooth muscle relaxation and arterial vasodilation, resulting in increased blood flow to pelvic tissues. In female anatomical structures, PDE5 is expressed within clitoral and vaginal smooth muscle tissue. Enhanced localized perfusion can promote clitoral engorgement and vaginal fluid transudation during sexual stimulation. However, because female sexual response involves integrated neuroendocrine and psychological pathways, enzymatic PDE5 inhibition addresses only vascular mechanics and does not directly alter neurochemical desire.

Main uses

Sildenafil citrate is FDA-approved under specific trade names for erectile dysfunction in adult males and pulmonary arterial hypertension in adult populations. Use of sildenafil under the name Femalegra for female sexual interest/arousal disorder (FSIAD) or antidepressant-induced female sexual dysfunction constitutes an off-label indication in the United States. Clinical trials evaluating PDE5 inhibitors in women have demonstrated variable efficacy outcomes, showing potential benefit primarily in secondary sexual dysfunction related to selective serotonin reuptake inhibitor (SSRI) therapy or specific vascular etiologies. Prescribers evaluate individual medical histories to determine if off-label sildenafil therapy is appropriate.

What to expect when starting treatment

Upon oral administration, physiological onset of action generally occurs within 30 to 60 minutes, provided sexual stimulation is present. Patients may observe localized vascular effects, such as mild facial flushing, pelvic warmth, or heightened anatomical sensitivity as localized tissue blood flow increases. The duration of measurable hemodynamic activity typically spans four to five hours post-dose. Sildenafil does not possess aphrodisiac properties and does not directly induce libido or emotional readiness; physical physiological responses depend entirely on concurrent central neurochemical stimulation.

Dosing schedule

Dosage parameters for sildenafil citrate must be established individually by a licensed prescriber. The drug is administered orally with a full glass of water. In off-label protocols, administration typically occurs as a single oral dose taken approximately 30 to 60 minutes prior to anticipated sexual activity. Daily continuous dosing is generally not indicated unless explicitly structured by a physician. Administration must not exceed one single dose within a 24-hour period to prevent drug accumulation and lessen the risk of systemic cardiovascular adverse events.

What happens in the body

Following oral administration, sildenafil citrate is rapidly absorbed from the gastrointestinal tract. The absolute oral bioavailability is approximately 40%. Peak plasma concentrations (Cmax) are reached within 30 to 120 minutes (median: 60 minutes) in a fasted state. Co-administration with high-fat meals delays absorption, increasing the time to peak concentration (Tmax) by approximately 60 minutes and reducing Cmax by approximately 29%. Sildenafil is extensively metabolized by hepatic microsomal enzymes, predominantly cytochrome P450 3A4 (CYP3A4) and secondarily CYP2C9. The principal circulating metabolite, N-desmethyl sildenafil, demonstrates approximately 50% of the parent compound’s PDE5 selectivity. The terminal elimination half-life ranges from 3 to 5 hours. Excretion occurs primarily as metabolites in the feces (approximately 80%) and secondarily in the urine (approximately 13%).

Safety Guidelines and Precautions

Food and alcohol interactions

Dietary factors significantly influence sildenafil pharmacokinetics. Consuming a high-fat meal immediately prior to ingestion delays drug absorption and lowers systemic peak levels, which may reduce initial clinical efficacy. Concomitant intake of grapefruit juice is contraindicated, as grapefruit components inhibit hepatic CYP3A4 enzymes, potentially elevating sildenafil plasma concentrations and increasing the frequency of adverse effects. Simultaneous ingestion of ethanol (alcohol) introduces additive vasodilatory hazards. Combining alcohol with sildenafil may induce orthostatic hypotension, dizziness, headache, and syncope.

What not to combine

Sildenafil citrate exhibits significant pharmacological interactions with several drug classes. Co-administration with organic nitrates (such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate) or nitric oxide donors (such as amyl nitrite) is strictly contraindicated due to the risk of precipitating severe, life-threatening systemic hypotension. Concurrent use with alpha-adrenergic blockers (e.g., doxazosin, tamsulosin) or other antihypertensive agents mandates careful titration, as combined vasodilatory effects may result in symptomatic hypotension. Potent CYP3A4 inhibitors–including ketoconazole, itraconazole, clarithromycin, and HIV protease inhibitors like ritonavir–substantially increase systemic sildenafil exposure, requiring conservative dosage adjustments or complete avoidance.

What side effects may occur

Adverse reactions associated with sildenafil citrate stem predominantly from its systemic PDE5 and secondary PDE6 inhibitory activity. Common side effects include headache, transient facial flushing, nasal congestion, dyspepsia, and mild visual disturbances (such as cyanopsia, blurred vision, or altered light perception). Less common adverse reactions include dizziness, back pain, myalgia, and epistaxis. Rare but serious events include Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), sudden sensorineural hearing loss, severe hypotension, and systemic hypersensitivity reactions. Patients experiencing severe systemic symptoms must seek immediate clinical evaluation.

Red flags

Certain acute clinical signs require immediate emergency medical care. Patients must seek emergency intervention if they experience sudden visual impairment or complete vision loss in one or both eyes, sudden loss or reduction of hearing accompanied by tinnitus or vertigo, acute retrosternal chest pain, severe dyspnea, or cardiac arrhythmias. Signs of a severe allergic reaction–such as angioedema involving the face, lips, tongue, or pharynx, generalized urticaria, or severe difficulty swallowing–also represent critical emergencies requiring immediate attention at an emergency room, such as a trauma facility in Chicago or local emergency care center.

Important precautions

Prescribers must evaluate cardiovascular risk prior to initiating sildenafil therapy. The medication should be used with extreme caution in patients with underlying ischemic heart disease, severe left ventricular outflow obstruction, resting hypotension (blood pressure < 90/50 mmHg), or uncontrolled hypertension. Hepatic impairment and severe renal impairment (creatinine clearance < 30 mL/min) reduce drug clearance, necessitating lower initial dosages. Concerning pregnancy and lactation, sildenafil safety for female sexual dysfunction has not been established in well-controlled human studies. Use during pregnancy or breastfeeding is not recommended unless explicitly advised by a specialist evaluating maternal-fetal risk-benefit ratios.

Storage and expiration

Sildenafil tablets should be stored at controlled room temperature between 68°F and 77°F (20°C to 25°C), with temporary excursions permitted between 59°F and 86°F (15°C to 30°C) under United States Pharmacopeia (USP) guidelines. Store the preparation in its original container to protect the tablets from moisture and light exposure. Do not store medication in environments with high humidity, such as bathroom cabinets. Keep out of reach of children and domestic animals. Unused or expired medication must be disposed of in accordance with US FDA drug disposal protocols or local pharmacy take-back programs.

Key Questions and Answers

How does sildenafil differ from FDA-approved therapies for female hypoactive sexual desire disorder?

Sildenafil is a peripherally acting PDE5 inhibitor that targets physiological vascular perfusion in pelvic tissue. In contrast, FDA-approved therapies for female hypoactive sexual desire disorder (such as flibanserin or bremelanotide) target central nervous system neurotransmitter receptors (including serotonin and dopamine systems) to modulate psychological sexual desire directly. Sildenafil does not act on central neurochemistry or alter desire.

Is sildenafil safe to combine with oral hormonal contraceptives?

There are no established direct cytochrome P450 pharmacokinetic drug interactions between sildenafil citrate and standard combined oral hormonal contraceptives. However, underlying metabolic or vascular risk factors must be thoroughly reviewed by a licensed healthcare provider before initiating concurrent therapy.

What is the standard procedure if a dose of sildenafil is omitted?

Because sildenafil for female sexual dysfunction is prescribed on an as-needed basis prior to sexual activity rather than a continuous daily schedule, missed doses do not disrupt a chronic regimen. If a dose is skipped, the patient simply resumes dosing before the next planned activity. Patients must never take a double dose to compensate for an omitted administration.

Can sildenafil intake alter systemic blood pressure readings?

Yes, sildenafil produces modest, transient reductions in systemic blood pressure due to its vasodilatory mechanism. In healthy individuals, these changes are typically clinically asymptomatic. However, in patients taking antihypertensive medications or nitrates, blood pressure drops can become pronounced and dangerous.

Is driving recommended after consuming sildenafil?

Sildenafil can cause transient neurological and visual side effects, including dizziness, lightheadedness, and temporary changes in color vision or visual acuity. Individuals should assess their personal physiological response to the drug before driving a motor vehicle or operating machinery.

In accordance with FDA requirements.

Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.

Additional information
Dosage

100mg

Package

10 pills

,

20 pills

,

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία